GC tissues; adjacent normal tissues; plasma; plasma exosome samples
GES-1; MGC-803; MKN-45; AGS; BGC-823
-
proliferation (other); migration (other); invasion (other); metastasis (inhibits); ceRNA regulation (other); other pathway/process (other); immune regulation (other)
RT-qPCR; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Cohort Study; Survival Analysis; Bioinformatics Analysis; Transfection
Tissue- and plasma-derived CDR1as have diagnostic potential for GC; tissue-derived CDR1as is an independent predictor for overall survival and a potential prognostic biomarker.
This study found that CDR1as is dysregulated in gastric cancer: it is downregulated in GC tissues and cell lines but upregulated in plasma and plasma exosomes. Tissue-derived CDR1as showed diagnostic value and independently predicted overall survival, with lower tissue expression associated with shorter survival. Proteomic and bioinformatic analyses suggested that CDR1as regulates GC-related biological processes through downstream proteins and pathways, including miRNA signaling networks, glycine/serine/threonine metabolism, and HSPE1.
0.6815
CircRNA CDR1as: a novel diagnostic and prognostic biomarker for gastric cancer.
combined biological and clinical study